Temozolomide: too early for definitive conclusions.
D000328:Adult; D000367:Age Factors; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects / Q000494:pharmacology*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D002648:Child; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000209:etiology; D003606:Dacarbazine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology*; D018450:Disease Progression; D005910:Glioma / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D011832:Radiation Injuries; D015203:Reproducibility of Results; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide